Posted inCritical Care Hematology-Oncology news Septic Shock in Allogeneic Hematopoietic Stem-Cell Transplant Recipients: Outcomes, Prognostic Factors, and Clinical Implications from a Multicenter ICU Cohort Posted by By MedXY 09/03/2026No Comments Highlight Septic shock is a leading cause of ICU admission among allo-HSCT recipients, with a 63% mortality at 90 days. Higher SOFA scores, fungal infections, and neutropenia independently predict poorer 90-day survival after septic shock. Early aminoglycoside therapy correlates with improved short-term survival, though its causal role remains uncertain. Age, graft-versus-host disease type, and early bacterial documentation do not independently affect 90-day mortality. MedXY View All Posts Post navigation Previous Post Validating the Venous Excess Ultrasound Score (VExUS) for Right Atrial Pressure Assessment in Pulmonary Hypertension: A Multicenter StudyNext PostMezigdomide Reverses T-Cell Exhaustion Through IKZF1/IKZF3 Degradation and Cytokine Pathway Reinvigoration in Multiple Myeloma
